Bruce C. Galton

All filings by Bruce C. Galton on record concern Eloxx Pharmaceuticals, Inc. Between 19 May 2005 and 1 December 2009, the trades on record add up to 17 filings.

The open-market side counts 1 purchase for €6,271 alongside 10 sales for €25k. Taken together, the sales exceed the purchases by €18k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 4 share grants. Since January 2009: no purchases and 2 sales on the market.

Most recently, on 2 December 2009, the filings show an open-market sale worth €7,164 in Eloxx Pharmaceuticals, Inc. The last purchase on record was published on 24 April 2006, which is 7,504 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.